Microbiome Therapeutics Innovation Group
Research - Washington, District of Columbia, United States
Microbiome Therapeutics Innovation Group Employees
Microbiome Therapeutics Innovation Group Details
The Microbiome Therapeutics Innovation Group (MTIG) is a coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs. The human microbiome is one of the new frontiers of medical innovation that has the potential to benefit patients suffering from numerous diseases afflicting millions of patients and consuming billions of dollars of healthcare resources. MTIG is committed to working with stakeholders who share in our mission and seek tangible policy and regulatory solutions in the emerging microbiome arena. Through a collective voice, the MTIG membership works together to enhance the regulatory, investment, and commercial environment to accelerate microbiome therapeutic product development and enable the field to reach its potential to benefit patients. Today, MTIG is comprised of five microbiome therapeutics companies: Rebiotix, Inc., Seed Health, Seres Therapeutics, Siolta Therapeutics and Vedanta Biosciences.
Microbiome Therapeutics Innovation Group Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Hosted Forms
Gravity Forms
Fonts
Google Font API
Other
Microsoft Office 365
Hosting
Flywheel